Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 09/01/15 | 8-K12G3 | Notification that a class of securities of successor issuer is deemed to be registered pursuant to Section 12(g) |
|
36 | |
| 08/24/15 | SC TO-I | Issuer tender offer statement |
|
50 | |
| 08/20/15 | S-1/A | General form of registration statement for all companies including face-amount certificate companies |
|
   |
103 |
| 08/19/15 | 8-K/A | Current report filing |
|
38 | |
| 08/04/15 | 8-K | Current report filing |
|
3 | |
| 08/03/15 | 8-K | Current report filing |
|
3 | |
| 07/23/15 | 8-K | Current report filing |
|
4 | |
| 07/20/15 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/17/15 | DEF 14A | Definitive proxy statements |
|
79 | |
| 07/17/15 | 3 | Initial statement of beneficial ownership of securities |
|
1 |
